BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24830761)

  • 1. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.
    Arthur AE; Peterson KE; Shen J; Djuric Z; Taylor JM; Hebert JR; Duffy SA; Peterson LA; Bellile EL; Whitfield JR; Chepeha DB; Schipper MJ; Wolf GT; Rozek LS
    Cancer; 2014 Sep; 120(17):2704-12. PubMed ID: 24830761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis.
    Arthur AE; Peterson KE; Rozek LS; Taylor JM; Light E; Chepeha DB; Hébert JR; Terrell JE; Wolf GT; Duffy SA;
    Am J Clin Nutr; 2013 Feb; 97(2):360-8. PubMed ID: 23269814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
    Hoffmann TK; Sonkoly E; Homey B; Scheckenbach K; Gwosdz C; Bas M; Chaker A; Schirlau K; Whiteside TL
    Head Neck; 2007 May; 29(5):472-8. PubMed ID: 17111427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.
    Shkeir O; Athanassiou-Papaefthymiou M; Lapadatescu M; Papagerakis P; Czerwinski MJ; Bradford CR; Carey TE; Prince ME; Wolf GT; Papagerakis S
    Head Neck; 2013 Nov; 35(11):1542-50. PubMed ID: 23322448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.
    Druzgal CH; Chen Z; Yeh NT; Thomas GR; Ondrey FG; Duffey DC; Vilela RJ; Ende K; McCullagh L; Rudy SF; Muir C; Herscher LL; Morris JC; Albert PS; Van Waes C
    Head Neck; 2005 Sep; 27(9):771-84. PubMed ID: 15920746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.
    Lathers DM; Achille NJ; Young MR
    Hum Immunol; 2003 Dec; 64(12):1160-6. PubMed ID: 14630398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment Dietary Patterns Are Associated with the Presence of Nutrition Impact Symptoms 1 Year after Diagnosis in Patients with Head and Neck Cancer.
    Crowder SL; Sarma KP; Mondul AM; Chen YT; Li Z; Pepino MY; Zarins KR; Wolf GT; Rozek LS; Arthur AE
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1652-1659. PubMed ID: 31315911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
    J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.
    Lathers DM; Young MR
    Cytokine; 2004 Mar; 25(5):220-8. PubMed ID: 15036248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma.
    Andersson BÅ; Lewin F; Lundgren J; Nilsson M; Rutqvist LE; Löfgren S; Laytragoon-Lewin N
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):515-9. PubMed ID: 24481866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between dietary patterns and head and neck cancer: the Carolina head and neck cancer epidemiology study.
    Bradshaw PT; Siega-Riz AM; Campbell M; Weissler MC; Funkhouser WK; Olshan AF
    Am J Epidemiol; 2012 Jun; 175(12):1225-33. PubMed ID: 22575416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with Lactobacillus Retards the Tumor Growth of Head and Neck Squamous Cell Carcinoma Cells Inoculated in Mice.
    Miyaguchi J; Shiga K; Ogawa K; Suzuki F; Katagiri K; Saito D; Ikeda A; Horii A; Watanabe M; Igimi S
    Tohoku J Exp Med; 2018 Aug; 245(4):269-275. PubMed ID: 30158369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
    Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.
    Mojtahedi Z; Khademi B; Hashemi SB; Abtahi SM; Ghasemi MA; Fattahi MJ; Ghaderi A
    Pathol Oncol Res; 2011 Mar; 17(1):7-10. PubMed ID: 20340055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck.
    Soylu L; Ozcan C; Cetik F; Paydaş S; Kiroğlu M; Aydoğan B; Sargin O; Ozşahinoglu C; Seyrek E
    Am J Otolaryngol; 1994; 15(4):281-5. PubMed ID: 7978027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prognostic biomarkers in head and neck cancer patients.
    Lin HS; Siddiq F; Talwar HS; Chen W; Voichita C; Draghici S; Jeyapalan G; Chatterjee M; Fribley A; Yoo GH; Sethi S; Kim H; Sukari A; Folbe AJ; Tainsky MA
    Laryngoscope; 2014 Aug; 124(8):1819-26. PubMed ID: 24347532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.